(Q36186475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Paul B McCray

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Sauter SL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1089-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302570

30 December 2019

exact match

0 references

cites work

Lentiviral vectors: optimization of packaging, transduction and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Factors influencing the titer and infectivity of lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Optimization of transgene expression at the posttranscriptional level in neural cells: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Corneal Transduction to Inhibit Angiogenesis and Graft Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

No false start for novel pseudotyped vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Optimized large-scale production of high titer lentivirus vector pseudotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Covalent modifications of the ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Targeting a Retroviral Vector in the Absence of a Known Cell-Targeting Ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Retroviral delivery of the ecdysone-regulatable gene expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Development of ecdysone-regulated lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Recruitment of histone modifications by USF proteins at a vertebrate barrier element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Insulators: many functions, many mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

HIV-1 integration in the human genome favors active genes and local hotspots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Genome-wide analyses of avian sarcoma virus integration sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Virology. Picking the right spot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Controlling integration specificity of a yeast retrotransposon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Targeting survival: integration site selection by retroviruses and LTR-retrotransposons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

21 January 2018

Integration by design

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

HIV vector production mediated by Rev protein transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Continuous high-titer HIV-1 vector production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Comparison of transfection conditions for a lentivirus vector produced in large volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Exploration of critical parameters for transient retrovirus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Novel integrating adenoviral/retroviral hybrid vector for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Foamy virus--adenovirus hybrid vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Integration efficiency of a hybrid adenoretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Vaccinia viral/retroviral chimeric vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

State-of-the-art of the production of retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Clinical grade vector production: analysis of yield, stability, and storage of gmp-produced retroviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Retrovirus vector production and transduction: modulation by the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

The temperature stability of mouse retroviruses depends on the cholesterol levels of viral lipid shell and cellular plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Characterization and detection of artificial replication-competent lentivirus of altered host range

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Determination of Infectious Retrovirus Concentration from Colony-Forming Assay with Quantitative Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Safety of retroviral gene marking with a truncated NGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Single-tube fluorescent product-enhanced reverse transcriptase assay with Ampliwax (STF-PERT) for retrovirus quantitation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302570

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16003340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference